Techcyte began as an idea to classify white blood cells using computer vision from Dr. Mohamed Salama which was purchased by Ralph Yarro in a technology transfer from the University of Utah in 2013. Since that initial idea, Techcyte has led the cellular digital pathology revolution by combining the knowledge and skills of a lab professional or pathologist with the latest deep learning technologies to provide the healthcare industries with digital diagnostic solutions.

Techcyte believes that individual cells hold clues to diagnosing disease. By analyzing cell morphology, phenotypic characteristics can reveal genotype, conditions, and diseases, getting us closer to providing precision medicine. 

Connect with Ben on Linkedin or follow him on Twitter @ben_cahoon.